Biophargroup is a premium Pharmaceutical industry which is into manufacturing of plethora of products ranging from tablets, Capsules, Injections, Ayurvedic Medicines, Syrups, Softgel, Creams & Powders and Dental Solutions. The pharma franchise aims for patient safety by producing quality medicines in their in-house manufacturing unit which has latest machines for quality manufacturing.
The pharmaceutical industry in most ASEAN markets is growing and dynamic, although at variant rates. The growth is driven by several factors, including the emergence of more efficient health systems that are expanding access for consumers wherein both innovative and generic pharmaceutical sectors are benefiting from this growth. The Pharmaceutical Industry in India is one of the largest in the world. It is ranked 4th in the World pertaining to the volume of sales. The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, and it accounts for 20 per cent in the volume terms and 1.4 per cent in value terms of the Global Pharmaceutical Industry. India is a massive provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. The consolidation is an important characteristic of the Indian pharmaceutical market as the industry is highly fragmented. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms
It is expected that The Indian pharmaceutical market size will grow to US$ 100 billion by 2025, due to an increase in consumer spending, rapid urbanization and raising healthcare insurance. Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.
To boost the pharmaceutical industry, the Indian government has also taken several steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also portend well for the pharmaceutical companies.
The Pharma PCD company hold a strong opinion that Indian pharmaceutical manufacturing companies is making their presence globally and leaving no stone unturned to compete with the pharmaceutical companies from the developed countries.
No comments:
Post a Comment